Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Gpr126 functions in Schwann cells to control differentiation and myelination via G-protein activation.
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Benzothiazole and stilbene derivatives as promising PET myelin radiotracers for multiple sclerosis.
Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm.
Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.
Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice.
The Charcot Lecture | Beating MS: A story of B cells, with twists and turns.
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells.
Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration.
LKB1/STRAD promotes axon initiation during neuronal polarization.
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.
Incidence of infusion-associated reactions with rituximab for treating multiple sclerosis: a retrospective analysis of patients treated at a US centre.
Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.
Prediction of oxygen uptake during walking in ambulatory persons with multiple sclerosis.
Ampyra (dalfampridine)
Extension CombiRx data show no benefit of combined MS drugs
Getting a Handle on Lymphopenia With Tecfidera
Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature.
Testing the measurement invariance of the University of Washington Self-Efficacy Scale short form across four diagnostic subgroups.
Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis.
Multiple sclerosis: clinical presentation, diagnosis and treatment.
An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.
Dimethyl fumarate (BG-12, Tecfidera) - NICE says yes in draft final guidance
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.

Pages